Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian share markets remain in green
Tue, 23 Jul 11:30 am

Indian share markets have remained in green during the previous two hours of trade. The most noticeable upward movements have been witnessed in consumer durables and banks' shares.

The BSE Sensex is up by 155 points and the NSE-Nifty is up by 50 points. BSE Mid Cap is up by 0.5% and BSE Small Cap is up by 0.3%. The rupee is trading at 59.66 to the US dollar.

Except Tube Investments and Escorts, all Automobiles' shares are trading in green with Mah. Scooters and Eicher Motor leading the gains. According to a leading financial news medium, Tata Motors' Chairman, Cyrus Mistry cautioned that the company will continue to face challenges this fiscal year too. The Company's passenger vehicles sale was significantly lower as compared to expectation. The car and utility vehicles sales witnessed 31% decline last year. Rapid changes in customer preferences and de-regulation in diesel pricing were the reasons cited by the management. According to the sales data provided by the Society of Indian Automobile Manufacturers (SIAM), the passenger vehicles sales stood at 229,325 units for the Company last financial year. That accounted for merely 8.9% of the market share. Tata Motors' fall in car sales included a 28% slump in sales of the Nano brand during the previous financial year.

The sales pressure is expected to continue this year as the competition continues to intensify. Overall, the domestic auto industry has reported a growth of 2% in the last financial year.

Profitability for the company declined by 76% to Rs 3 bn in the last financial year. That said, the management is confident of a turnaround for the company on the back of new product launches. The Company is already working on a slew of new products with strategic plan in place till 2020. This includes increased emphasis on alternate fuels, hybrids and electric vehicles. Tata Motors' share is up by 0.03%.

Except few, such as Torrent Pharma, Cadila Healthcare and Sun Pharma, most of the Indian pharma shares are trading in green with Fresenius Kabi Oncoand Panacea Biotech leading the gains. According to a leading financial news daily, Lupin Ltd, the pharmaceutical major, has received US health regulator's approval to sell its generic version of Glumetza HCI ER tablets, a diabetes drug, in the American market. As per IMS health data, Glumetza HCI ER tablets of 500 mg and 1000 mg has reported sales of nearly USD 144 mn in the US market in 2012-13.The Company's U.S. subsidiary Lupin Pharmaceuticals Inc., has received final approval for its Metformin Hydrochloride extended release tablets (HCI ER) 500 mg and 1000 mg from the United States Food and Drugs Administration (FDA). Metaformin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

This comes as a positive development for Lupin. Going forward, the growth for the Company would be largely driven by new launches in US segment and in the domestic market. However, increasing competition in global generics, penetration in oral contraceptive space, higher tax rates and exposure to currency risks are the major concern areas for the company. Lupin Ltd's share is up by 0.6%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian share markets remain in green". Click here!

  

Related Views on News

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Mar 5, 2021 (Close)

TRACK LUPIN

LUPIN - TEVA PHARMA COMPARISON

COMPARE LUPIN WITH

MARKET STATS